Quarterly Activities Report and Appendix 4C
| Stock | Little Green Pharma Ltd (LGP.ASX) |
|---|---|
| Release Time | 31 Jul 2026, 8:54 a.m. |
| Price Sensitive | Yes |
Little Green Pharma Merger with Cannatrek Completed
- Merger with Cannatrek Ltd completed on 1 June 2026
- Net cash from operating activities of $1.8 million for the quarter
- Total cash and cash equivalents of $20.6 million at 30 June 2026
- Initiated capital investment in UK and German growth initiatives
- Minimal debt of $5.9 million as at 1 June 2026
Little Green Pharma Ltd (ASX: LGP) has merged with Cannatrek Ltd to form the LGP Cannatrek Group, a leading global medicinal cannabis company. The merger was completed on 1 June 2026, and the quarterly report highlights the financial and operational progress since the merger. Key financial highlights include net cash from operating activities of $1.8 million for the quarter, total cash and cash equivalents of $20.6 million at 30 June 2026, and minimal debt of $5.9 million as at 1 June 2026. The report also notes the initiation of capital investments in the UK and German growth initiatives, including the expansion of the Denmark facility. The merger has reweighted the Group's sales mix, with approximately 60% from Cannatrek and 40% from LGP, and 75% from core brands. The Group is progressing on seven core workstreams to achieve the targeted $3 million in synergies across various functions.
Total cash and cash equivalents of $20.6 million at 30 June 2026
The LGP Cannatrek Group is expected to accelerate scaling of European operations and support its international growth agenda, with ongoing investments in the UK and German markets.